Skip to main content
. 2011 Dec 1;9:205. doi: 10.1186/1479-5876-9-205

Table 2.

Correlation between AEG-1 expression and clinicopathologic characteristics of SGC

Characteristics AEG-1 expression Chi-square test P-value
Low or none No. cases (%) High
No. cases (%)
Gender Male 42 (29.79) 37 (26.24) 0.160
Female 20 (14.18) 42 (29.79)
Age (years) < 48 32 (22.70) 40 (28.37) 0.908
≥ 48 30 (21.28) 39 (27.66)
Clinical Stage I 10 (7.09) 6 (4.26) 0.001
II 28 (19.86) 21 (16.31)
III 13 (9.22) 21 (14.89)
IV 11 (7.80) 31 (21.99)
T classification T1 10 (7.09) 7 (4.96) 0.008
T2 31 (21.99) 29 (20.57)
T3 13 (9.22) 20 (14.18)
T4 8 (5.67) 23 (16.31)
N classification N0 53 (37.59) 53 (37.59) 0.008
N1 6 (4.26) 11 (7.80)
N2 3 (2.13) 15 (10.64)
M classification No 51 (36.17) 48 (34.04) 0.006
Yes 11 (7.8) 31 (21.99)
Histological Types Mucoepidermoid carcinoma 13 (9.22) 21 (14.89) 0.48
Adenoid cystic carcinoma 10 (7.09) 10 (7.09)
Acinar cell carcinoma 9 (6.38) 12 (8.51)
Adenocarcinoma 8 (5.67) 15 (10.64)
Squamous cell carcinoma 6 (4.26) 6 (4.26)
Salivary duct carcinoma 10 (7.09) 6 (4.26)
Basal cell carcinoma 6 (4.26) 9 (6.38)
Drinking No 55(39.01) 62 (43.97) 0.110
Yes 7(4.96) 17 (12.06)
Smoking No 48 (34.04) 53 (37.59) 0.178
Yes 14 (9.93) 26 (18.44)